Recent Quotes (30 days)

You have no recent quotes
chg | %

Response Biomedical Corp  

(Public, TSE:RBM)   Watch this stock  
Find more results for RBM
0.000 (0.00%)
Apr 27 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.34 - 1.00
Open     -
Vol / Avg. 0.00/1,575.00
Mkt cap 9.93M
P/E     -
Div/yield     -
EPS -0.01
Shares 9.93M
Beta 2.81
Inst. own     -
May 18, 2016
Response Biomedical Corp Annual Shareholders Meeting (Estimated) - 2:00PM EDT - Add to calendar
May 3, 2016
Q1 2016 Response Biomedical Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 22, 2016
Q4 2015 Response Biomedical Corp Earnings Release

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 20.66% -18.98%
Operating margin 6.52% -45.70%
EBITD margin - -36.67%
Return on average assets 22.18% -15.02%
Return on average equity - -
Employees 65 -
CDP Score - -


1781 75th Ave W
+1-604-4566010 (Phone)
+1-604-4566066 (Fax)

Website links


Response Biomedical Corp. (Response) is a Canada-based company engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets. The Company develops, manufactures and sells its RAMP system for the global medical point of care market, including cardiovascular testing, infectious disease testing market and the on-site environmental testing market, including biodefense and vector environmental testing. In the United States, its RAMP 200 Reader is limited to central-lab use with the cardiovascular tests. POC, on-site diagnostic tests (or assays), are non-laboratory based tests performed using portable hand-held devices, compact desktop analyzers, single-use test cartridges and/or dipsticks.

Officers and directors

Barbara R. Kinnaird Ph.D. Chief Executive Officer, Director
Age: 48
William J. Adams Chief Financial Officer, Secretary
Age: 53
Lewis J. Shuster Chairman of the Board
Age: 60
Anthony F. Holler M.D. Director
Age: 63
Peter A. Thompson M.D. Director
Age: 56
Jonathan J. Wang Ph.D. Director
Age: 47
Joseph D. Keegan Ph.D. Independent Director
Age: 61
Clinton H. Severson Independent Director
Age: 67